Synergistic cytotoxicity of radiation and oncolytic Lister strain vaccinia in V600D/EBRAF mutant melanoma depends on JNK and TNF-α signaling

Oncolytic Vaccinia virus and radiotherapy in head and neck cancer

(2012) D. Mansfield et al.   ORAL ONCOLOGY

Permissivity of the NCI-60 cancer cell lines to oncolytic Vaccinia Virus GLV-1h68

(2011) Maria Libera Ascierto et al.   BMC CANCER

Synergistic effects of oncolytic reovirus and docetaxel chemotherapy in prostate cancer

(2011) Lucy Heinemann et al.   BMC CANCER

The Evolving Role of Radiation Therapy in the Management of Malignant Melanoma

(2011) Niloufer Khan et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation

(2011) Paul B. Chapman et al.   NEW ENGLAND JOURNAL OF MEDICINE

Kinase-Dead BRAF and Oncogenic RAS Cooperate to Drive Tumor Progression through CRAF

(2010) Sonja J. Heidorn et al.   CELL

Two-Stage Phase I Dose-Escalation Study of Intratumoral Reovirus Type 3 Dearing and Palliative Radiotherapy in Patients with Advanced Cancers

(2010) K. J. Harrington et al.   CLINICAL CANCER RESEARCH

REO-10: A Phase I Study of Intravenous Reovirus and Docetaxel in Patients with Advanced Cancer

(2010) C. Comins et al.   CLINICAL CANCER RESEARCH

Synergistic Effects of Oncolytic Reovirus and Cisplatin Chemotherapy in Murine Malignant Melanoma

(2009) H. S. Pandha et al.   CLINICAL CANCER RESEARCH

Phase II Trial of Temozolomide and Sorafenib in Advanced Melanoma Patients with or without Brain Metastases

(2009) R. K. Amaravadi et al.   CLINICAL CANCER RESEARCH

Phase II Study of Sorafenib in Patients With Metastatic or Recurrent Sarcomas

(2009) Robert G. Maki et al.   JOURNAL OF CLINICAL ONCOLOGY

Activation of the PI3K/Akt Pathway Early during Vaccinia and Cowpox Virus Infections Is Required for both Host Survival and Viral Replication

(2009) J. A. P. Soares et al.   JOURNAL OF VIROLOGY

Oncolytic vaccinia therapy of squamous cell carcinoma

(2009) Zhenkun Yu et al.   Molecular Cancer

Regression of human pancreatic tumor xenografts in mice after a single systemic injection of recombinant vaccinia virus GLV-1h68

(2009) Y. A. Yu et al.   MOLECULAR CANCER THERAPEUTICS

Use of an oncolytic vaccinia virus for the treatment of canine breast cancer in nude mice: preclinical development of a therapeutic agent

(2008) I Gentschev et al.   CANCER GENE THERAPY

Enhanced In vitro and In vivo Cytotoxicity of Combined Reovirus and Radiotherapy

(2008) K. Twigger et al.   CLINICAL CANCER RESEARCH

Novel Oncolytic Agent GLV-1h68 Is Effective Against Malignant Pleural Mesothelioma

(2008) Kaitlyn J. Kelly et al.   HUMAN GENE THERAPY

Oncolytic Vaccinia Virotherapy of Anaplastic Thyroid Cancerin Vivo

(2008) Shu-Fu Lin et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity

(2008) J. Tsai et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA